Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells

Hiroaki Itoh, Norimasa Sagawa, Masaaki Hasegawa, Atsuhiko Okagaki, Kumiko Inamori, Yoshiyuki Ihara, Takahide Mori, Yoshihiro Ogawa, Shin Ichi Suga, Masashi Mukoyama, Kazuwa Nakao, Hiroo Imura

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The presence and biochemical characteristics of human brain natriuretic peptide (hBNP) in the amniotic fluid at various gestational ages were investigated. The hBNP-like immunoreactivity (hBNP-LI) levels in amniotic fluid, determined by RIA, were 118.7 ± 57.6 pmol/L (mean ± SEM; n = 5) and 107.7 ± 8.7 pmol/L (n = 9) in the first and second trimesters of pregnancy, respectively; it was significantly decreased to 28.4 ± 5.1 pmol/L (n = 9) in the third trimester. However, human atrial natriuretic peptide-like immunoreactivity (hANP-LI) was not detected (< 0.3 pmol/L) in any of these samples. Northern blot analysis demonstrated hBNP mRNA in human amnion tissue. Moreover, cultured amnion cells secreted a significant amount of hBNP-LI (100-200 fmol/10 6 cells/day), but not hANP-LI, into the culture medium. The synthesis of hBNP in cultured amnion cells was further confirmed using the polymerase chain reaction. High performance gel permeation chromatography of hBNP-LI extracted from human amniotic fluid and the culture medium of amnion cells revealed that the predominant molecular form of hBNP-LI in both samples was the hBNP precursor, with an approximate mol wt of 12 kilodaltons. These findings indicate that hBNP is present in the human amniotic fluid, and that amnion cells synthesize hBNP and secrete it into the amniotic cavity.

Original languageEnglish
Pages (from-to)907-911
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume76
Issue number4
DOIs
Publication statusPublished - Jan 1 1993
Externally publishedYes

Fingerprint

Amnion
Brain Natriuretic Peptide
Amniotic Fluid
Fluids
Atrial Natriuretic Factor
Culture Media
Cultured Cells
Polymerase chain reaction
Gel permeation chromatography
Third Pregnancy Trimester
Second Pregnancy Trimester
First Pregnancy Trimester
Tissue

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells. / Itoh, Hiroaki; Sagawa, Norimasa; Hasegawa, Masaaki; Okagaki, Atsuhiko; Inamori, Kumiko; Ihara, Yoshiyuki; Mori, Takahide; Ogawa, Yoshihiro; Suga, Shin Ichi; Mukoyama, Masashi; Nakao, Kazuwa; Imura, Hiroo.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 76, No. 4, 01.01.1993, p. 907-911.

Research output: Contribution to journalArticle

Itoh, H, Sagawa, N, Hasegawa, M, Okagaki, A, Inamori, K, Ihara, Y, Mori, T, Ogawa, Y, Suga, SI, Mukoyama, M, Nakao, K & Imura, H 1993, 'Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells', Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 4, pp. 907-911. https://doi.org/10.1210/jcem.76.4.8473404
Itoh, Hiroaki ; Sagawa, Norimasa ; Hasegawa, Masaaki ; Okagaki, Atsuhiko ; Inamori, Kumiko ; Ihara, Yoshiyuki ; Mori, Takahide ; Ogawa, Yoshihiro ; Suga, Shin Ichi ; Mukoyama, Masashi ; Nakao, Kazuwa ; Imura, Hiroo. / Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells. In: Journal of Clinical Endocrinology and Metabolism. 1993 ; Vol. 76, No. 4. pp. 907-911.
@article{33ee10db91c3468385b7bf475cb2ca13,
title = "Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells",
abstract = "The presence and biochemical characteristics of human brain natriuretic peptide (hBNP) in the amniotic fluid at various gestational ages were investigated. The hBNP-like immunoreactivity (hBNP-LI) levels in amniotic fluid, determined by RIA, were 118.7 ± 57.6 pmol/L (mean ± SEM; n = 5) and 107.7 ± 8.7 pmol/L (n = 9) in the first and second trimesters of pregnancy, respectively; it was significantly decreased to 28.4 ± 5.1 pmol/L (n = 9) in the third trimester. However, human atrial natriuretic peptide-like immunoreactivity (hANP-LI) was not detected (< 0.3 pmol/L) in any of these samples. Northern blot analysis demonstrated hBNP mRNA in human amnion tissue. Moreover, cultured amnion cells secreted a significant amount of hBNP-LI (100-200 fmol/10 6 cells/day), but not hANP-LI, into the culture medium. The synthesis of hBNP in cultured amnion cells was further confirmed using the polymerase chain reaction. High performance gel permeation chromatography of hBNP-LI extracted from human amniotic fluid and the culture medium of amnion cells revealed that the predominant molecular form of hBNP-LI in both samples was the hBNP precursor, with an approximate mol wt of 12 kilodaltons. These findings indicate that hBNP is present in the human amniotic fluid, and that amnion cells synthesize hBNP and secrete it into the amniotic cavity.",
author = "Hiroaki Itoh and Norimasa Sagawa and Masaaki Hasegawa and Atsuhiko Okagaki and Kumiko Inamori and Yoshiyuki Ihara and Takahide Mori and Yoshihiro Ogawa and Suga, {Shin Ichi} and Masashi Mukoyama and Kazuwa Nakao and Hiroo Imura",
year = "1993",
month = "1",
day = "1",
doi = "10.1210/jcem.76.4.8473404",
language = "English",
volume = "76",
pages = "907--911",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells

AU - Itoh, Hiroaki

AU - Sagawa, Norimasa

AU - Hasegawa, Masaaki

AU - Okagaki, Atsuhiko

AU - Inamori, Kumiko

AU - Ihara, Yoshiyuki

AU - Mori, Takahide

AU - Ogawa, Yoshihiro

AU - Suga, Shin Ichi

AU - Mukoyama, Masashi

AU - Nakao, Kazuwa

AU - Imura, Hiroo

PY - 1993/1/1

Y1 - 1993/1/1

N2 - The presence and biochemical characteristics of human brain natriuretic peptide (hBNP) in the amniotic fluid at various gestational ages were investigated. The hBNP-like immunoreactivity (hBNP-LI) levels in amniotic fluid, determined by RIA, were 118.7 ± 57.6 pmol/L (mean ± SEM; n = 5) and 107.7 ± 8.7 pmol/L (n = 9) in the first and second trimesters of pregnancy, respectively; it was significantly decreased to 28.4 ± 5.1 pmol/L (n = 9) in the third trimester. However, human atrial natriuretic peptide-like immunoreactivity (hANP-LI) was not detected (< 0.3 pmol/L) in any of these samples. Northern blot analysis demonstrated hBNP mRNA in human amnion tissue. Moreover, cultured amnion cells secreted a significant amount of hBNP-LI (100-200 fmol/10 6 cells/day), but not hANP-LI, into the culture medium. The synthesis of hBNP in cultured amnion cells was further confirmed using the polymerase chain reaction. High performance gel permeation chromatography of hBNP-LI extracted from human amniotic fluid and the culture medium of amnion cells revealed that the predominant molecular form of hBNP-LI in both samples was the hBNP precursor, with an approximate mol wt of 12 kilodaltons. These findings indicate that hBNP is present in the human amniotic fluid, and that amnion cells synthesize hBNP and secrete it into the amniotic cavity.

AB - The presence and biochemical characteristics of human brain natriuretic peptide (hBNP) in the amniotic fluid at various gestational ages were investigated. The hBNP-like immunoreactivity (hBNP-LI) levels in amniotic fluid, determined by RIA, were 118.7 ± 57.6 pmol/L (mean ± SEM; n = 5) and 107.7 ± 8.7 pmol/L (n = 9) in the first and second trimesters of pregnancy, respectively; it was significantly decreased to 28.4 ± 5.1 pmol/L (n = 9) in the third trimester. However, human atrial natriuretic peptide-like immunoreactivity (hANP-LI) was not detected (< 0.3 pmol/L) in any of these samples. Northern blot analysis demonstrated hBNP mRNA in human amnion tissue. Moreover, cultured amnion cells secreted a significant amount of hBNP-LI (100-200 fmol/10 6 cells/day), but not hANP-LI, into the culture medium. The synthesis of hBNP in cultured amnion cells was further confirmed using the polymerase chain reaction. High performance gel permeation chromatography of hBNP-LI extracted from human amniotic fluid and the culture medium of amnion cells revealed that the predominant molecular form of hBNP-LI in both samples was the hBNP precursor, with an approximate mol wt of 12 kilodaltons. These findings indicate that hBNP is present in the human amniotic fluid, and that amnion cells synthesize hBNP and secrete it into the amniotic cavity.

UR - http://www.scopus.com/inward/record.url?scp=0027480374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027480374&partnerID=8YFLogxK

U2 - 10.1210/jcem.76.4.8473404

DO - 10.1210/jcem.76.4.8473404

M3 - Article

VL - 76

SP - 907

EP - 911

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -